Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4168)
All Articles published online
|
Jan 14, 2012 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tsapralis D, Panayiotides I, Peros G, Liakakos T, Karamitopoulou E. Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology. World J Gastroenterol 2012; 18(2): 150-155 [PMID: 22253521 DOI: 10.3748/wjg.v18.i2.150] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i2/150.htm |
| Number | Citing Articles |
| 1 |
Hiroshi Yoshida, Noriko Yamamoto, Hirokazu Taniguchi, Ichiro Oda, Hitoshi Katai, Ryoji Kushima, Hitoshi Tsuda. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma. Virchows Archiv 2014; 465(2): 145 doi: 10.1007/s00428-014-1597-3
|
| 2 |
Hao Wu, Zhenzhai Cai, Guangrong Lu, Shuguang Cao, He Huang, Yi Jiang, Weijian Sun. Impact of c-erbB-2 Protein on 5-year Survival Rate of Gastric Cancer Patients after Surgery: A Cohort Study and Meta-analysis. Tumori Journal 2017; 103(3): 249 doi: 10.5301/tj.5000444
|
| 3 |
Narikazu Boku. HER2-positive gastric cancer. Gastric Cancer 2014; 17(1): 1 doi: 10.1007/s10120-013-0252-z
|
| 4 |
Julita Machlowska, Ryszard Maciejewski, Robert Sitarz. The Pattern of Signatures in Gastric Cancer Prognosis. International Journal of Molecular Sciences 2018; 19(6): 1658 doi: 10.3390/ijms19061658
|
| 5 |
Fang Zhou, Wensheng Qiu, Lingling Sun, Jinyu Xiang, Xiaoxiao Sun, Aihua Sui, Aiping Ding, Lu Yue. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers. APMIS 2013; 121(7): 582 doi: 10.1111/apm.12043
|
| 6 |
Juhee Jeong, Duk Ki Kim, Ji-Hyeon Park, Do Joong Park, Hyuk-Joon Lee, Han-Kwang Yang, Seong-Ho Kong, Keehoon Jung. Tumor-Infiltrating Neutrophils and Non-Classical Monocytes May Be Potential Therapeutic Targets for HER2negative Gastric Cancer. Immune Network 2021; 21(4) doi: 10.4110/in.2021.21.e31
|
| 7 |
Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi, Hee Kyung Chang, Soomin Ahn, Mee Soo Chang, Song-Hee Han, Yoonjin Kwak, An Na Seo, Sung Hak Lee, Mee-Yon Cho. A Standardized Pathology Report for Gastric Cancer: 2nd Edition. Journal of Gastric Cancer 2023; 23(1): 107 doi: 10.5230/jgc.2023.23.e7
|
| 8 |
MELIKE DINCCELIK-ASLAN, GUVEM GUMUS-AKAY, ATILLA HALIL ELHAN, EKREM UNAL, AJLAN TUKUN. Diagnostic and prognostic significance of glypican 5 and glypican 6 gene expression levels in gastric adenocarcinoma. Molecular and Clinical Oncology 2015; 3(3): 584 doi: 10.3892/mco.2015.486
|
| 9 |
Daisuke Kotani, Kohei Shitara. Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer. Therapeutic Advances in Medical Oncology 2021; 13: 175883592098651 doi: 10.1177/1758835920986518
|
| 10 |
Takahiro Ishii, Kohei Shitara. Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancer. Expert Review of Anticancer Therapy 2021; 21(11): 1193 doi: 10.1080/14737140.2021.1982698
|
| 11 |
Atieh Yaghoubi, Saman Soleimanpour, Majid Khazaei. Molecular Hydrogen in Health and Disease. Advances in Biochemistry in Health and Disease 2024; 27: 261 doi: 10.1007/978-3-031-47375-3_17
|
| 12 |
A. Creemers, E. ter Veer, L. de Waal, P. Lodder, G. K. J. Hooijer, N. C. T. van Grieken, M. F. Bijlsma, S. L. Meijer, M. G. H. van Oijen, H. W. M. van Laarhoven. Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03304-9
|
| 13 |
Maria Apicella, Simona Corso, Silvia Giordano. Targeted therapies for gastric cancer: failures and hopes from clinical trials. Oncotarget 2017; 8(34): 57654 doi: 10.18632/oncotarget.14825
|
| 14 |
A. Ieni, V. Barresi, L. Rigoli, R. A. Caruso, G. Tuccari. HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/234851
|
| 15 |
Antonio Ieni, Roberta Cardia, Cristina Pizzimenti, Pio Zeppa, Giovanni Tuccari. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies. Journal of Personalized Medicine 2020; 10(1): 10 doi: 10.3390/jpm10010010
|
| 16 |
Qichun Wei, Jing Xu, Li Shen, Xianhua Fu, Bicheng Zhang, Xiaofeng Zhou, Jorgen Carlsson. HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides. Tumor Biology 2014; 35(7): 6319 doi: 10.1007/s13277-014-1830-3
|
| 17 |
Shigehiro Koganemaru, Kohei Shitara. Antibody–drug conjugates to treat gastric cancer. Expert Opinion on Biological Therapy 2021; 21(7): 923 doi: 10.1080/14712598.2020.1802423
|
| 18 |
Taroh Satoh, Rui-Hua Xu, Hyun Cheol Chung, Guo-Ping Sun, Toshihiko Doi, Jian-Ming Xu, Akihito Tsuji, Yasushi Omuro, Jin Li, Jin-Wan Wang, Hiroto Miwa, Shu-Kui Qin, Ik-Joo Chung, Kun-Huei Yeh, Ji-Feng Feng, Akihira Mukaiyama, Mikiro Kobayashi, Atsushi Ohtsu, Yung-Jue Bang. Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study. Journal of Clinical Oncology 2014; 32(19): 2039 doi: 10.1200/JCO.2013.53.6136
|
| 19 |
Chen Zeng, Ran Yan, Guanghua Yang, Sen Xiang, Fuli Zhao. Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial–mesenchymal transition of gastric cancer cells. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20193181
|
| 20 |
Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi, Hee Kyung Chang, Soomin Ahn, Mee Soo Chang, Song-Hee Han, Yoonjin Kwak, An Na Seo, Sung Hak Lee, Mee-Yon Cho. A standardized pathology report for gastric cancer: 2nd edition. Journal of Pathology and Translational Medicine 2023; 57(1): 1 doi: 10.4132/jptm.2022.12.23
|